RNA interference (RNAi) is a natural mechanism used by the body to turn genes off without permanently changing DNA. It controls how and when genes are turned into proteins and is part of the innate immune response to viruses. RNAi occurs when a small RNA (a microRNA, small interfering RNA or antisense RNA) binds to messenger RNA (mRNA) and stops it from being turned into a protein product.
RNAi can turn off any gene in the genome and so is used in scientific research to discover the genetic cause of different diseases and in RNA medicines to treat diseases caused by too much protein or by defective proteins.
May 30, 2017
Arcturus Therapeutics to Receive Up to $3 Million from Cystic Fibrosis Foundation Therapeutics to Advance a Novel LUNAR-Formulated mRNA CFTR Therapeutic
August 23, 2017
Pictures by Ernst and Young (Finalists for the Entrepreneur Of The Year 2017 Award® in San Diego)
August 9, 2017
Arcturus Therapeutics in the list of Cystic Fibrosis Key Companies